KMID : 0882420130840050742
|
|
Korean Journal of Medicine 2013 Volume.84 No. 5 p.742 ~ p.746
|
|
Successful Rechallenge with Darbepoetin Following Immunosuppressive Therapy in a Dialysis Patient with Erythropoietin-Induced Pure Red Cell Aplasia
|
|
Son In-Sung
Kim Do-Young Park Soo-Youn Na Ha-Young Lee Jung-Hyun Heo Tae-Hwe Jo Young-Il
|
|
Abstract
|
|
|
Patients with erythropoiesis-stimulating agent (ESA)-induced pure red cell aplasia (PRCA) should not routinely be switched to an alternative ESA or to darbepoetin-¥á because anti-erythropoietin (anti-EPO) antibodies cross-react with all kinds of recombinant ESAs. We present a case of ESA-induced PRCA in a 69-year-old man on hemodialysis whose anemia improved with reintroduction of darbepoetin-¥á following immunosuppressive therapy. The patient developed severe anemia after 15 months of subcutaneous administration of erythropoietin-¥á. After the diagnosis of PRCA, erythropoietin-¥á was discontinued and immunosuppressive therapy with a combination of prednisolone and oral cyclophosphamide was initiated. After 4 months of immunosuppressive therapy, the anti-EPO antibody titer was markedly decreased; however, esophageal candidiasis developed. Additional therapy with cyclosporine alone instead of prednisone and cyclophosphamide was performed, and anti-EPO antibody was subsequently not detected. Darbepoetin-¥á was then reintroduced, and the patient¡¯s anemia improved without red cell transfusion. In conclusion, ESA-induced PRCA was successfully treated with reintroduction of darbepoetin-¥á following immunosuppressive therapy.
|
|
KEYWORD
|
|
Pure red cell aplasia, Erythropoietin, Antibodies, Anemia
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|